(lp0
S'Atossa Genetics Inc  Should Continue To Run This Quarter Insider Financial - Feb 9, 2017 Atossa Genetics Inc  is lighting up scanners everywhere, having scored gains of more than 20% mid week and looking set to pick up further strength as the week draws to a close.'
p1
aS"Ambitious Atossa Genetics Going After Two Breast Cancer Blockbusters Seeking Alpha - Dec 10, 2015 That technology is now licensed to Atossa Genetics , a small biotech about 1/7900th of Abbvie's size. Atossa has licensed a gel reformulation of AstraZeneca's  Nolvadex, better known as generic tamoxifen. Tamoxifen is the most popular&nbsp;..."
p2
aS"BRIEF-Atossa Genetics amends qtrly loss to $0.04/shr in Form 10-Q amendment ... Reuters - Mar 21, 2017 Atossa Genetics Inc - amendment no. 1 to quarterly report on Form 10-Q amends company's quarterly report on Form 10-Q for quarter ended June 30, 2016."
p3
aS"Atossa Genetics Inc. : A Detailed Look at its Institutional Ownership Post Analyst - 21 hours ago Atossa Genetics Inc.  reached -0.77% versus a 1-year low price of $1.18. The stock was last seen -11.03% lower, reaching at $1.29 on Mar. 21, 2017.Atossa Genetics Inc.'s  stock price is worth at $1.29 per share - Street UpdatesAt the Focal Point, Checking in on Atossa Genetics Inc.  - Morgan Research"
p4
aS'Atossa Genetics Inc. ATOS  Wall Street Journal - Oct 2, 2012 Atossa Genetics Inc. ATOS . search. View All companies. AT CLOSE 4:00 PM EST 03/10/17. $1.50 USD; -0.04 -2.60%.'
p5
aS'Technicals in Focus for Atossa Genetics Inc  Midway Monitor - 9 hours ago Traders are taking a second look at how shares of Atossa Genetics Inc  have been performing lately. A favorite tool among technical stock analysts is the moving average.Company Watch: Checking the Numbers for Atossa Genetics Inc  - Rives Journal'
p6
aS'Atossa Genetics Inc  Explodes Up The Charts Insider Financial - Feb 19, 2016 Shares of Atossa Genetics Inc  have exploded up the charts recently on news of insider buying and optimism for upcoming clinical trial updates.'
p7
aS"Atossa Genetics: Spotty Track Record And Short On Cash Seeking Alpha  - Feb 26, 2015 Atossa Genetics  went up over 40% in early trading when it announced Henry Schein will offer Atossa Genetics' FullCYTE Breast Aspirator on Feb 26th, 2015. Traders and investors have been repetitively trapped by this type of trivial news&nbsp;..."
p8
aS'Atossa Genetics Inc.  likely to see bigger moves on its earnings ... Post Analyst - Mar 20, 2017 Atossa Genetics Inc.  is trading down on a volume of 0.06 million, or 0.6 times its standard daily volume. Shares have dropped -5.2% to $1.46.'
p9
aS'Atossa Genetics  Stock Declines Today on Heavy Trading Volume TheStreet.com - Dec 29, 2014 NEW YORK  -- Shares of Atossa Genetics  are down 8.5% to $1.72 on heavy trading volume after the healthcare company, focused on the development and marketing of cellular and molecular diagnostic risk assessment products for breast&nbsp;...'
p10
a.